Info

Intrexon Corporation is a privately-held life sciences company headquartered at the Virginia Tech Corporate Research Center in Blacksburg, Virginia, with additional R&D operations in Valley Forge, Pennsylvania. The company is focused on the research and development of transcriptional therapeutics for critical human diseases that have proven intractable for traditional drug modalities. Intrexon's transcriptional platform enables unparalleled control and specificity of complex gene programs, including inducible, multigenic programs that modulate specific protein - protein interactions in targeted subcellular locations.